Johnson & Johnson has approved a new logo.
The healthcare behemoth announced Thursday that it will replace its well-known distinctive script, which it has used since 1887, with a more modern design that reflects its increased emphasis on pharmaceuticals and medical devices.
The original script, based on co-founder James Wood Johnson’s signature, will be featured on consumer products such as infant shampoo from Kenvue, a new firm spun out from J&J.
J&J has focused on drugs and medical devices. The new appearance, which features a distinct shade of red, intends to reflect J&J’s transformation into a “pure play health care company,” according to executive vice president Vanessa Broadhurst.
J&J’s trademark logo was “one of the longest-used company emblems in the world,” according to a 2017 website post.
However, it began to show its age in an age of texting and emoticons.
Johnson & Johnson has approved a new logo.
According to marketing strategist Laura Ries, many youngsters no longer learn to write cursive in school. According to her, people may have recognized the signature but needed to be reading it. She claims that the new logo is easier to understand.
“Because it’s easier, it almost draws your attention to it,” Ries, who was not involved in the logo change, said.
Ries also discovered that customers were likelier to associate the script logo with Kenvue products on drugstore shelves, such as Band-Aids, Listerine, and Tylenol.
Johnson & Johnson has approved a new logo.
“Everyone washed their babies with Johnson & Johnson baby shampoo,” she explained.
According to a Kenvue spokeswoman, the J&J logo on products such as Band-Aids will be gradually erased.
The distinctive emblem was also found on bottles of the company’s now-discontinued talcum-based infant powder, which sparked cancer lawsuits. J&J has stated that the powder was completely safe.
J&J’s consumer business helped the company become the world’s largest manufacturer of healthcare items, with annual revenues exceeding $90 billion. However, by the time the split was announced in late 2021, its pharmaceutical and medical device divisions had comfortably overtaken it in size.
J&J, based in New Brunswick, New Jersey, J&J will also rebrand its Janssen pharmaceutical division to J&J Innovative Medicine. Its medical device and technology division will be known as MedTech.
SOURCE – (AP)
